Rhabdastrellic acid-A induced autophagy-associated cell death through blocking Akt pathway in human cancer cells

Dan-Dan Li1, Jing-Feng Guo, Jia-Jia Huang

  • 1State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, Guangzhou, China.

Plos One
|September 3, 2010
PubMed
Abstract

Insights

Rhabdastrellic acid-A, a compound from a marine sponge, inhibits cancer cell growth and triggers cell death by inducing autophagy. This process involves blocking the Akt pathway, suggesting potential as an anticancer agent.

Area of Science:

  • Marine natural products
  • Cellular biology
  • Cancer research

Background:

  • Autophagy is a crucial protein degradation pathway.
  • Dysfunctional autophagy is linked to cancer development.
  • Autophagy inducers show promise in cancer prevention and therapy.

Purpose of the Study:

  • To investigate the anticancer effects of Rhabdastrellic acid-A.
  • To determine the mechanism of Rhabdastrellic acid-A-induced cancer cell death.
  • To explore the role of autophagy in Rhabdastrellic acid-A's action.

Main Methods:

  • Tested Rhabdastrellic acid-A on human cancer cell lines (Hep3B, A549).
  • Assessed cell proliferation and induced cell death.
  • Utilized YFP-LC3 punctation and LC3-II assays to confirm autophagy.
  • Employed autophagy inhibitors (3-MA) and gene knockdown (Atg5).
  • Analyzed Akt pathway signaling (phospho-Akt) and used Akt pathway modulation.

Main Results:

  • Rhabdastrellic acid-A inhibited proliferation and induced caspase-independent cell death in Hep3B and A549 cells.
  • The compound triggered autophagy, evidenced by YFP-LC3 punctation and increased LC3-II.
  • Autophagy inhibition (3-MA, Atg5 knockdown) reduced Rhabdastrellic acid-A-induced cell death.
  • Rhabdastrellic acid-A decreased phospho-Akt levels, and active Akt blocked its effects.

Conclusions:

  • Rhabdastrellic acid-A induces autophagy-associated cell death in cancer cells by inhibiting the Akt pathway.
  • This marine-derived compound warrants further investigation as a potential anticancer or cancer preventive agent.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...